Spectrum of epithelial neoplasms in end-stage renal disease: An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia

American Journal of Surgical Pathology

Volumn 30, Issue 2, 2006, Pages 141-153

  Tickoo, Satish K ^a   DePeralta Venturina, Mariza N ^b,c   Harik, Lara R ^a   Worcester, Heath D ^d   Salama, Mohamed E ^c   Young, Andrew N ^d   Moch, Holger ^e   Amin, Mahul B ^d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Acquired cystic disease of kidney; Acquired cystic disease associated renal cell carcinoma; Clear cell papillary renal cell carcinoma of the end stage kidneys; End stage renal disease; Immunohistochemistry; Papillary renal cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CLEAR CELL CARCINOMA; EPITHELIUM TUMOR; EXPERIENCE; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; TUMOR BIOPSY; CHRONIC KIDNEY FAILURE; DIFFERENTIAL DIAGNOSIS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

TUMOR MARKER;

ADULT; AGED; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 33645216355     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000185382.80844.b1     Document Type: Article

References (45)

1. Aita K, Tanimoto A, Fujimoto Y, et al. Sarcomatoid collecting duct carcinoma arising in the hemodialysis-associated acquired cystic kidney: an autopsy report. Pathol Int. 2003;53:463-467.
2. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA. 1993;90:7915-7922.
3. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26:281-291.
4. Cheuk W, Lo ES, Chan AK, et al. Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations. Hum Pathol. 2002;33:761-765.
5. Choyke PL. Acquired cystic kidney disease. Eur Radiol. 2000;10:1716-1721.
6. Chung WY, Nast CC, Ettenger RB, et al. Acquired cystic disease in chronically rejected renal transplants. J Am Soc Nephrol. 1992;2:1298-1301.
7. Chung-Park M, Parveen T, Lam M. Acquired cystic disease of the kidneys and renal cell carcinoma in chronic renal insufficiency without dialysis treatment. Nephron. 1989;53:157-161.
8. Covarsi A, Rodriguez AM, Marigliano N, et al. Metastasizing renal cell carcinoma and acquired renal cystic disease in a hemodialysis patient. Am J Nephrol. 1991;11:224-228.
9. Denton MD, Magee CC, Ovuworie C, et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int. 2002;61:2201-2209.
10. Doublet JD, Peraldi MN, Gattegno B, et al. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol. 1997;158:42-44.
11. Dry SM, Renshaw AA. Extensive calcium oxalate crystal deposition in papillary renal cell carcinoma: report of two cases. Arch Pathol Lab Med. 1998;122:260-261.
12. Eble JN, Sauter G, Epstein JI, et al. WHO classification of tumours. In: Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press, 2004.
13. Goswami A, Singhal PC, Wagner JD, et al. Matrix modulates uptake of calcium oxalate crystals and cell growth of renal epithelial cells. J Urol. 1995;153:206-211.
14. Hammes MS, Lieske JC, Pawar S, et al. Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney Int. 1995;48:501-509.
15. Hughson MD, Buchwald D, Fox M. Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med. 1986;110:592-601.
16. Hughson MD, Buchwald D, Fox M. Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med. 1986;110:592-601.
17. Hughson MD, Schmidt L, Zbar B, et al. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study. J Am Soc Nephrol. 1996;7:2461-2468.
18. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology. 1993;22:135-139.
19. Ishikawa I, Saito Y, Asaka M, et al. Twenty-year follow-up of acquired renal cystic disease. Clin Nephrol. 2003;59:153-159.
20. Storkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997;80:987-989.
21. Kuroda N, Naruse K, Miyazaki E, et al. Vinculin: its possible use as a marker of normal collecting ducts and renal neoplasms with collecting duct system phenotype. Mod Pathol. 2000;13:1109-1114.
22. Laird PW, Jaenisch R. DNA methylation and cancer. Hum Mol Genet. 1994;3:1487-1495.
23. Levine E. Acquired cystic kidney disease. Radiol Clin North Am. 1996; 34:947-964.
24. Lieske JC, Walsh-Reitz MM, Toback FG. Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol. 1992;262:F622-F630.
25. Manabe S, Suzuki M, Kusano E, et al. Elevation of levels of carcinogenic tryptophan pyrolysis products in plasma and red blood cells of patients with uremia. Clin Nephrol. 1992;37:28-33.
26. Matson MA, Cohen EP. Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore). 1990;69:217-226.
27. Paner GP, Srigley JR, Young AN, et al. Immunohistochemistry in the differential diagnosis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: innovations and pitfalls. Mod Pathol. 2005;18:157A.
28. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am. 1993;7:431-445.
29. Perna AF, Ingrosso D, De Santo NG, et al. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney Int. 1995;47:247-253.
30. Pope JC, Koch MO, Bluth RF. Renal cell carcinoma in patients with end-stage renal disease: a comparison of clinical significance in patients receiving hemodialysis and those with renal transplants. Urology. 1994;44:497-501.
31. Radhakrishnan A, Lim SD, Patel A, et al. Utility of contemporary immunohistochemical panel in the differential diagnosis of adult renal epithelial neoplasms: a study in tissue microarrays to simulate experience in renal biopsy specimens. Mod Pathol. 2004;17:173A.
32. Reuter VE, Tickoo SK. Adult renal tumors. In: Mills SE, Carter D, Greenson JK, et al, eds. Sternberg's Diagnostic Surgical Pathology, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004:1955-2000.
33. Rioux-Leclercq NC, Epstein JI. Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney. Arch Pathol Lab Med. 2003;127:E89-E92.
34. Shingleton WB, Blalock J, Clark J, et al. Renal cell carcinoma in native kidneys of patients with end stage renal disease. J Miss State Med Assoc. 1998;39:86-89.
35. Skinnider BF, Folpe AL, Hennigar RA, et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol. 2005;29:747-754.
36. Sule N, Yakupoglu U, Shen SS, et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol. 2005;29:443-451.
37. Suvarna SK, Ahuja M, Brown CB. Sarcomatoid renal cell carcinoma arising in hemodialysis-associated acquired cystic kidney disease presenting with disseminated bone marrow infiltration. Am J Kidney Dis. 1994;24:581-585.
38. Tickoo SK, de Peralta-Venturina MN, Salama M, et al. Spectrum of epithelial tumors in end-stage renal disease: emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Lab Invest. 2003;83:173A.
39. Tretiakova MS, Sahoo S, Takahashi M, et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol. 2004;28:69-76.
40. Umekawa T, Chegini N, Khan SR. Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int. 2002;61:105-112.
41. Vamvakas S, Bahner U, Becker P, et al. Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation. Transplant Proc. 1996;28:3468-3473.
42. Vamvakas S, Bahner U, Heidland A. Cancer in end-stage renal disease: potential factors involved -editorial review. Am J Nephrol. 1998;18:89-95.
43. Yanagisawa H, Wada O. Significant increase of IQ-type heterocyclic amines, dietary carcinogens in the plasma of patients with uremia just before induction of hemodialysis treatment. Nephron. 1989;52:6-10.
44. Yoshimura S, Suemizu H, Nomoto Y, et al. Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron. 1996;73:207-211.
45. Young AN, de Oliveira Salles PG, Lim SD, et al. Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol. 2003;27:199-205.